AU2354600A - Grnf4 a neurotrophic factor - Google Patents

Grnf4 a neurotrophic factor

Info

Publication number
AU2354600A
AU2354600A AU23546/00A AU2354600A AU2354600A AU 2354600 A AU2354600 A AU 2354600A AU 23546/00 A AU23546/00 A AU 23546/00A AU 2354600 A AU2354600 A AU 2354600A AU 2354600 A AU2354600 A AU 2354600A
Authority
AU
Australia
Prior art keywords
grnf4
neurotrophic factor
neurotrophic
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23546/00A
Inventor
Franklin J. Asuncion
Shuqian Jing
Hosung Min
William Scott Simonet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU2354600A publication Critical patent/AU2354600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU23546/00A 1998-12-09 1999-12-08 Grnf4 a neurotrophic factor Abandoned AU2354600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11162698P 1998-12-09 1998-12-09
US60111626 1998-12-09
PCT/US1999/028975 WO2000034475A2 (en) 1998-12-09 1999-12-08 Grnf4, a gdnf-related neurotrophic factor

Publications (1)

Publication Number Publication Date
AU2354600A true AU2354600A (en) 2000-06-26

Family

ID=22339556

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23546/00A Abandoned AU2354600A (en) 1998-12-09 1999-12-08 Grnf4 a neurotrophic factor

Country Status (4)

Country Link
EP (1) EP1137774A2 (en)
JP (1) JP2002531128A (en)
AU (1) AU2354600A (en)
WO (1) WO2000034475A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111566204A (en) * 2017-11-10 2020-08-21 再生医科学股份有限公司 Method for producing cultured cell and method for producing therapeutic agent for spinal cord injury disease

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593133B1 (en) * 1998-07-06 2003-07-15 Nsgene A/S Neurotrophic factors
US20020055467A1 (en) * 1998-07-06 2002-05-09 Johansen Teit E. Novel neurotrophic factors
US7067473B1 (en) 1998-07-14 2006-06-27 Janssen Pharmaceutica N.V. Neurotrophic growth factor
HU226073B1 (en) † 1998-07-14 2008-04-28 Janssen Pharmaceutica Nv Neurotrophic growth factor
EP1873244A3 (en) * 1999-06-02 2008-04-02 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
US7442370B2 (en) * 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
JP4259868B2 (en) * 2001-02-01 2009-04-30 バイオジェン・アイデック・エムエイ・インコーポレイテッド Neublastin polymer conjugates and similar uses.
US7276580B2 (en) 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
NZ529126A (en) * 2001-03-28 2010-07-30 Biogen Idec Inc Use of neublastin polypeptides for treating allodynia, hyperalgesic pain and phantom pain
WO2004022701A2 (en) * 2001-07-15 2004-03-18 Keck Graduate Institute Exponential amplification of nucleic acids using nicking agents
SI2246362T1 (en) * 2003-01-31 2014-04-30 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
US8722862B2 (en) 2004-08-19 2014-05-13 Biogen Idec Ma Inc. Refolding transforming growth factor beta family proteins
TWI501774B (en) 2006-02-27 2015-10-01 Biogen Idec Inc Treatments for neurological disorders
TWI445544B (en) 2007-05-01 2014-07-21 Biogen Idec Inc Compositions and methods for increasing vascularization
US7993666B2 (en) * 2008-04-18 2011-08-09 Warsaw Orthopedic, Inc. Methods and compositions for treating pain comprising a statin
EP3538560A4 (en) 2016-11-10 2020-06-17 Keros Therapeutics, Inc. Gdnf fusion polypeptides and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0888385T3 (en) * 1996-03-14 2003-12-15 Genentech Inc GDNF receptor and uses thereof
US6593133B1 (en) * 1998-07-06 2003-07-15 Nsgene A/S Neurotrophic factors
HU226073B1 (en) * 1998-07-14 2008-04-28 Janssen Pharmaceutica Nv Neurotrophic growth factor
CA2344277A1 (en) * 1998-09-22 2000-03-30 University Of Maryland, Baltimore Cystine knot growth factor mutants
US6284540B1 (en) 1998-09-29 2001-09-04 Washington University Artemin, a novel neurotrophic factor

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111566204A (en) * 2017-11-10 2020-08-21 再生医科学股份有限公司 Method for producing cultured cell and method for producing therapeutic agent for spinal cord injury disease
CN111566204B (en) * 2017-11-10 2024-03-26 再生医科学股份有限公司 Method for producing cultured cells and method for producing therapeutic agent for spinal cord injury disease

Also Published As

Publication number Publication date
WO2000034475A2 (en) 2000-06-15
WO2000034475A3 (en) 2000-11-09
EP1137774A2 (en) 2001-10-04
WO2000034475A9 (en) 2002-08-29
JP2002531128A (en) 2002-09-24

Similar Documents

Publication Publication Date Title
AU4798097A (en) A transcoder
AU4998999A (en) A truss structure
AU1026300A (en) A stroller
AU2354600A (en) Grnf4 a neurotrophic factor
AU1886597A (en) A microreactor
AU1396097A (en) A bio-enhancer
AU7165998A (en) Neurotrophic factor receptors
AU9736998A (en) A noisescreen
AU2636299A (en) A lighting system
AU4051899A (en) A coathanger
AU5998199A (en) New bis-benzimidazoles
AU1921900A (en) A polysome
AU1170700A (en) A castor
AU4920797A (en) A square
AU690505B3 (en) A pre-knotted knecktie
AUPP580598A0 (en) A jack
AUPP486198A0 (en) A boardgame
AU5278999A (en) A covered stand
AU2156099A (en) A transformer
AUPP162398A0 (en) A demountable structure
AUPP561798A0 (en) A fitting
AUPP359298A0 (en) A novel method-IV
AUPP166598A0 (en) A novel method - iii
AUPP259998A0 (en) A ventilator
AU679666B3 (en) A lotto-checker

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase